查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1887032

微創手術器材市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察，以及2024年至2032年的預測

Minimally Invasive Surgery Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 請詢問到貨日

價格

微創手術 (MIS) 器械市場成長驅動因素

隨著醫療保健系統轉向能夠縮短恢復時間、最大限度減少創傷並提高手術精準度的手術方式，全球微創手術器械市場持續增長。根據2024年的產業估值，2024年微創手術器械市場規模將達到190.7億美元，這主要得益於心臟病學、骨科、婦科和胃腸病學等專科領域對微創手術的日益普及。預計到2025年，該市場規模將達到202.7億美元，並在2032年顯著增長至349.3億美元，2025年至2032年的複合年增長率（CAGR）為8.1%。

微創手術（MIS）器械，包括腹腔鏡器械、內視鏡、機器人輔助系統、擴張器械、導航系統和專用手術器械，使外科醫生能夠透過小切口或自然孔道進行複雜的手術，從而減輕患者的疼痛、感染風險並縮短住院時間。

北美將在2024年引領市場

2024年，北美持續維持在全球微創手術器械市場的領先地位，佔40.27%的市場佔有率（價值76.8億美元）。這一優勢歸功於其完善的醫療基礎設施、高手術量、機器人手術的廣泛應用以及對微創手術有利的報銷政策。預計到 2024 年，美國將擁有超過 6,300 家獲得聯邦醫療保險 (Medicare) 認證的門診手術中心 (ASC)，這將持續推動該地區對腹腔鏡和機器人手術解決方案的需求。

市場規模概覽 (2024-2032)

  • 2024 年：190.7 億美元
  • 2025 年：202.7 億美元
  • 2032 年：349.3 億美元

由於慢性病發生率上升、人口老化以及外科技術的進步，市場持續擴張。

主要國家亮點

美國

美國在骨科、心臟病學和胃腸病學領域的微創手術量方面處於世界領先地位。廣泛的保險覆蓋、主流手術機器人的普及以及美敦力、強生和直覺外科等公司的強大影響力，都支撐著美國市場的強勁勢頭。

日本

人口老化和對機器人技術的大力投資正在推動機器人輔助腹腔鏡和內視鏡手術的快速普及。醫院和學術機構正擴大採用新一代微創手術平台。

中國

截至2023年，60歲及以上人口將達到2.97億，慢性病盛行率的持續上升正在推動對微創手術的需求。對機器人平台的投資和三級醫院的擴建正在支持微創手術的廣泛應用。

歐洲

機器人輔助手術在英國和德國等國家正迅速普及。英國首例兒科機器人手術於2025年初完成，這反映了該地區先進的外科創新能力。

市場動態

驅動因素－慢性疾病日益增多

心血管疾病、癌症、糖尿病和肥胖等慢性疾病正在推動微創手術（MIS）數量的成長。根據英國心臟基金會（2025年）統計，全球有6.2億人患有心臟和循環系統疾病，因此對微創治療的需求持續增加。全球每年進行超過400萬例膝關節鏡手術，凸顯了骨科領域對微創手術的龐大需求。

限制因素－微創手術技術成本高

先進的微創手術工具，尤其是機器人系統，需要大量投資。像達文西手術系統這樣的設備售價約為200萬美元，還不包括維護和培訓費用，這限制了其在小型醫院和鄉村醫院的普及。

機會－門診手術中心的成長

到2024年，美國將擁有超過6300家獲得聯邦醫療保險認證的門診手術中心，大量微創手術轉移到門診進行，這催生了對影像導航微創手術器械的強勁需求。

挑戰－熟練外科醫生短缺

僅在美國，預計到2036年，外科醫生缺口將達到15800至30200人，這將影響微創手術能力，並減緩其在全球範圍內的普及。

市場趨勢

包括機器人輔助平台、人工智慧引導工具、3D視覺化和微型內視鏡在內的技術進步，不斷重新定義微創手術 (MIS) 的標準。美敦力公司向美國食品藥物管理局 (FDA) 提交的 Hugo RAS 系統申請、直覺外科公司達文西 5 系統於 2024 年獲批，以及單孔手術的創新，都顯示了該領域的快速發展。

近期趨勢包括：

  • 2025 年 4 月：美敦力公司擴大泌尿科機器人手術的臨床試驗。
  • 2024 年 3 月：直覺外科公司的達文西 5 系統獲得 FDA 批准。
  • 2023-2024 年：史賽克公司推出新型微創手術探針與 1788 微創手術攝影平台。

微創外科器械市場成長驅動因素

隨著醫療系統朝向能夠縮短恢復時間、減少創傷並提高手術精準度的手術方式轉型，全球微創外科器械市場持續成長。根據2024年的產業估值，微創外科器械市場規模預計將達到190.7億美元，這主要得益於心臟病學、骨科、婦科和胃腸病學等專科領域對微創手術的日益普及。預計到2025年，市場規模將達到202.7億美元，並在2032年顯著增長至349.3億美元，2025年至2032年的複合年增長率（CAGR）為8.1%。

微創手術（MIS）器械，包括腹腔鏡器械、內視鏡、機器人輔助系統、擴張器械、導航系統和專用手術器械，使外科醫生能夠透過小切口或自然孔道進行複雜的手術，從而減輕患者的疼痛、感染風險並縮短住院時間。

北美將在2024年引領市場

2024年，北美持續維持在全球微創手術器械市場的領先地位，佔40.27%的市場佔有率（價值76.8億美元）。這一主導地位歸功於其完善的醫療基礎設施、高手術量、機器人手術的廣泛應用以及對微創手術有利的報銷政策。預計到 2024 年，美國將擁有超過 6,300 家獲得聯邦醫療保險 (Medicare) 認證的門診手術中心 (ASC)，這將持續推動該地區對腹腔鏡和機器人手術解決方案的需求。

市場規模概覽 (2024-2032)

  • 2024 年：190.7 億美元
  • 2025 年：202.7 億美元
  • 2032 年：349.3 億美元

由於慢性病發生率上升、人口老化以及外科技術的進步，市場持續擴張。

主要國家亮點

美國

美國在骨科、心臟病學和胃腸病學領域的微創手術量方面處於世界領先地位。美國市場的強勁勢頭得益於廣泛的保險覆蓋、主流手術機器人的普及以及美敦力、強生和直覺外科等公司的強大影響力。

日本

人口老化和對機器人技術的大力投資正在推動機器人輔助腹腔鏡和內視鏡手術的快速普及。醫院和學術機構正擴大採用新一代微創手術平台。

中國

到2023年，60歲以上人口將達到2.97億，慢性病盛行率的持續上升將推動對微創手術的需求。對機器人平台的投資和三級醫療機構的擴建支持了微創手術的廣泛應用。

歐洲

機器人輔助手術在英國和德國等國家正迅速普及。英國首例兒科機器人手術於2025年初完成，這反映了該地區先進的外科創新能力。

市場動態

驅動因素－慢性疾病日益增多

心血管疾病、癌症、糖尿病和肥胖等慢性疾病正在推動微創手術（MIS）數量的成長。鑑於全球有6.2億人患有心臟和循環系統疾病（英國心臟基金會，2025），對微創治療的需求持續成長。全球每年進行超過400萬例膝關節鏡手術，凸顯了骨科領域對微創手術的巨大需求。

限制因素－微創手術技術成本高

先進的微創手術工具，尤其是機器人系統，需要大量投資。像達文西手術系統這樣的設備造價約為 200 萬美元，還不包括維護和培訓費用，這限制了其在小型和區域性醫院的普及。

機會－門診手術中心成長

截至 2024 年，美國已有超過 6300 家獲得聯邦醫療保險認證的門診手術中心，大量微創手術轉移到門診進行，這催生了對影像導航微創手術器械的強勁需求。

挑戰－熟練外科醫生短缺

僅在美國，預計到 2036 年外科醫生缺口就將達到 15800 至 30200 人，這將影響微創手術能力，並減緩其在全球範圍內的普及。

市場趨勢

包括機器人輔助平台、人工智慧引導工具、3D視覺化和微型內視鏡在內的技術進步，不斷重新定義微創手術 (MIS) 的標準。美敦力公司向美國食品藥物管理局 (FDA) 提交的 Hugo RAS 系統申請、直覺外科公司達文西 5 系統於 2024 年獲批，以及單孔手術的創新，都顯示了該領域的快速發展。

近期進展包括：

  • 2025 年 4 月：美敦力公司擴大泌尿科機器人手術的臨床試驗。
  • 2024 年 3 月：直覺外科公司的達文西 5 系統獲得 FDA 批准。
  • 2023-2024 年：史賽克公司推出新型微創手術探針與 1788 MIS 攝影機平台。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家和地區的主要手術量（2024 年）
  • 主要產業趨勢－併購、合作及其他
  • 概述：監管和報銷情況
  • 主要公司的新產品發布

第五章：全球微創手術器材市場分析、洞察與預測（2019-2032）

  • 市場分析、洞察與預測 - 依類型劃分
    • 充氣裝置
    • 引導裝置
    • 內視鏡裝置
    • 腹腔鏡裝置
    • 機器人輔助手術裝置
    • 導航視覺化系統
    • 其他
  • 市場分析、洞察與預測 - 依應用領域劃分
    • 心臟病學
    • 胃腸病學
    • 骨科
    • 婦科
    • 神經病學
    • 牙科
    • 其他
  • 市場分析、洞察與預測 - 依最終用戶劃分
    • 醫院及門診手術中心
    • 診所
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美微創外科器械市場分析、洞察與預測 （2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲微創外科器材市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章：亞太地區微創外科器械市場分析、洞察與預測（2019-2032）

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲微創手術器材市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲微創手術器材市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 海灣合作委員會
    • 南非
    • 中東其他地區非洲

第十一章 競爭分析

  • 全球市佔率分析（2024）
  • 公司簡介
    • 美敦力公司
    • 強生服務公司
    • 皇家飛利浦公司
    • 波士頓科學公司
    • 奧林巴斯公司
    • 史賽克公司
    • 貝朗公司
    • 史特瑞斯公司
    • 直覺外科公司
Product Code: FBI113274

Growth Factors of minimally invasive surgery (MIS) devices Market

The global minimally invasive surgery (MIS) devices market continues to gain momentum as healthcare systems increasingly shift toward procedures that reduce recovery time, minimize trauma, and enhance surgical precision. According to the 2024 industry assessment, the MIS devices market was valued at USD 19.07 billion in 2024, driven by rising adoption of MIS procedures across cardiology, orthopedics, gynecology, and gastrointestinal specialties. The market is expected to reach USD 20.27 billion in 2025 and expand significantly to USD 34.93 billion by 2032, exhibiting a strong CAGR of 8.1% from 2025 to 2032.

MIS devices-including laparoscopic tools, endoscopes, robotic-assisted systems, inflation devices, navigation systems, and specialized surgical instruments-enable surgeons to perform complex interventions through small incisions or natural orifices, reducing pain, infection risk, and hospital stays.

North America Leads the Market in 2024

North America dominated the global minimally invasive surgery devices market in 2024 with a 40.27% share, equivalent to USD 7.68 billion. This leadership stems from well-established healthcare infrastructure, high surgical volumes, widespread robotic surgery adoption, and favorable reimbursement policies for MIS procedures. The U.S., with more than 6,300 Medicare-certified Ambulatory Surgical Centers (ASCs) by 2024, continues to drive regional demand for laparoscopic and robotic solutions.

Market Size Overview (2024-2032)

  • 2024: USD 19.07 billion
  • 2025: USD 20.27 billion
  • 2032: USD 34.93 billion

The combination of rising chronic disease incidence, aging populations, and advancements in surgical technologies continues to propel the market forward.

Key Country Highlights

United States

The U.S. leads globally in MIS procedure volume across orthopedic, cardiology, and gastrointestinal applications. Extensive insurance coverage, major surgical robot installations, and strong presence of Medtronic, Johnson & Johnson, and Intuitive Surgical fuel U.S. market strength.

Japan

An aging population and strong robotics investment drive rapid adoption of robotic-assisted laparoscopic and endoscopic surgeries. Hospitals and academic centers increasingly integrate next-generation MIS platforms.

China

With 297 million individuals aged 60+ in 2023, chronic conditions continue to rise, driving MIS demand. Investments in robotic platforms and expanding tertiary care hospitals support broad MIS adoption.

Europe

Countries such as the U.K. and Germany show strong momentum in robotic-assisted surgeries. The U.K.'s first pediatric robotic surgery in early 2025 reflects the region's advanced surgical innovation capabilities.

Market Dynamics

Drivers - Rising Chronic Conditions

Chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity are driving MIS procedure volumes. With 620 million people worldwide living with heart and circulatory diseases (British Heart Foundation, 2025), the need for minimally invasive interventions continues expanding. Globally, over 4 million arthroscopic knee surgeries are performed annually, highlighting high orthopedic MIS demand.

Restraints - High Cost of MIS Technologies

Advanced MIS tools-especially robotic systems-require heavy investment. Systems like the Da Vinci Surgical System cost around USD 2 million, excluding maintenance and training, limiting adoption in smaller and rural hospitals.

Opportunities - Growth of Ambulatory Surgical Centers

With 6,300+ Medicare-certified ASCs in the U.S. (2024), the shift of high-volume MIS procedures to outpatient settings creates strong demand for imaging, navigation, and minimally invasive tools.

Challenges - Shortage of Skilled Surgeons

The U.S. alone faces a projected shortage of 15,800-30,200 surgeons by 2036, affecting MIS capacity and slowing global adoption.

Market Trends

Technological advancements-including robotic-assisted platforms, AI-guided tools, 3D visualization, and miniaturized endoscopes-continue to redefine MIS standards. Medtronic's FDA submission of the Hugo RAS system, Intuitive Surgical's da Vinci 5 clearance in 2024, and innovations in single-port surgery demonstrate the rapid evolution of the field.

Competitive Landscape

The market is dominated by industry leaders such as:

  • Medtronic
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Stryker
  • Olympus Corporation
  • Boston Scientific
  • Intuitive Surgical

These companies drive innovation through new launches, AI-integrated surgical solutions, and expansions in robotic surgery systems.

Recent developments include:

  • April 2025: Medtronic expands its URO robotic surgery clinical trial.
  • March 2024: Intuitive receives FDA clearance for da Vinci 5.
  • 2023-2024: Stryker introduces new minimally invasive surgical probe and 1788 MIS camera platform.

Growth Factors of minimally invasive surgery (MIS) devices Market

The global minimally invasive surgery (MIS) devices market continues to gain momentum as healthcare systems increasingly shift toward procedures that reduce recovery time, minimize trauma, and enhance surgical precision. According to the 2024 industry assessment, the MIS devices market was valued at USD 19.07 billion in 2024, driven by rising adoption of MIS procedures across cardiology, orthopedics, gynecology, and gastrointestinal specialties. The market is expected to reach USD 20.27 billion in 2025 and expand significantly to USD 34.93 billion by 2032, exhibiting a strong CAGR of 8.1% from 2025 to 2032.

MIS devices-including laparoscopic tools, endoscopes, robotic-assisted systems, inflation devices, navigation systems, and specialized surgical instruments-enable surgeons to perform complex interventions through small incisions or natural orifices, reducing pain, infection risk, and hospital stays.

North America Leads the Market in 2024

North America dominated the global minimally invasive surgery devices market in 2024 with a 40.27% share, equivalent to USD 7.68 billion. This leadership stems from well-established healthcare infrastructure, high surgical volumes, widespread robotic surgery adoption, and favorable reimbursement policies for MIS procedures. The U.S., with more than 6,300 Medicare-certified Ambulatory Surgical Centers (ASCs) by 2024, continues to drive regional demand for laparoscopic and robotic solutions.

Market Size Overview (2024-2032)

  • 2024: USD 19.07 billion
  • 2025: USD 20.27 billion
  • 2032: USD 34.93 billion

The combination of rising chronic disease incidence, aging populations, and advancements in surgical technologies continues to propel the market forward.

Key Country Highlights

United States

The U.S. leads globally in MIS procedure volume across orthopedic, cardiology, and gastrointestinal applications. Extensive insurance coverage, major surgical robot installations, and strong presence of Medtronic, Johnson & Johnson, and Intuitive Surgical fuel U.S. market strength.

Japan

An aging population and strong robotics investment drive rapid adoption of robotic-assisted laparoscopic and endoscopic surgeries. Hospitals and academic centers increasingly integrate next-generation MIS platforms.

China

With 297 million individuals aged 60+ in 2023, chronic conditions continue to rise, driving MIS demand. Investments in robotic platforms and expanding tertiary care hospitals support broad MIS adoption.

Europe

Countries such as the U.K. and Germany show strong momentum in robotic-assisted surgeries. The U.K.'s first pediatric robotic surgery in early 2025 reflects the region's advanced surgical innovation capabilities.

Market Dynamics

Drivers - Rising Chronic Conditions

Chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity are driving MIS procedure volumes. With 620 million people worldwide living with heart and circulatory diseases (British Heart Foundation, 2025), the need for minimally invasive interventions continues expanding. Globally, over 4 million arthroscopic knee surgeries are performed annually, highlighting high orthopedic MIS demand.

Restraints - High Cost of MIS Technologies

Advanced MIS tools-especially robotic systems-require heavy investment. Systems like the Da Vinci Surgical System cost around USD 2 million, excluding maintenance and training, limiting adoption in smaller and rural hospitals.

Opportunities - Growth of Ambulatory Surgical Centers

With 6,300+ Medicare-certified ASCs in the U.S. (2024), the shift of high-volume MIS procedures to outpatient settings creates strong demand for imaging, navigation, and minimally invasive tools.

Challenges - Shortage of Skilled Surgeons

The U.S. alone faces a projected shortage of 15,800-30,200 surgeons by 2036, affecting MIS capacity and slowing global adoption.

Market Trends

Technological advancements-including robotic-assisted platforms, AI-guided tools, 3D visualization, and miniaturized endoscopes-continue to redefine MIS standards. Medtronic's FDA submission of the Hugo RAS system, Intuitive Surgical's da Vinci 5 clearance in 2024, and innovations in single-port surgery demonstrate the rapid evolution of the field.

Competitive Landscape

The market is dominated by industry leaders such as:

  • Medtronic
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Stryker
  • Olympus Corporation
  • Boston Scientific
  • Intuitive Surgical

These companies drive innovation through new launches, AI-integrated surgical solutions, and expansions in robotic surgery systems.

Recent developments include:

  • April 2025: Medtronic expands its URO robotic surgery clinical trial.
  • March 2024: Intuitive receives FDA clearance for da Vinci 5.
  • 2023-2024: Stryker introduces new minimally invasive surgical probe and 1788 MIS camera platform.

Segmentation By Type

  • Inflation Devices
  • Guiding Devices
  • Endoscopic Devices
  • Laparoscopic Devices
  • Robotic Assistive Surgery Devices
  • Navigation & Visualization Systems
  • Others

By Application

  • Cardiology
  • Gastrointestinal
  • Orthopedic
  • Gynecological
  • Neurology
  • Dental
  • Others

By End-user

  • Hospitals & ASCs
  • Clinics
  • Others

By Geography

  • North America (By Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Key Surgeries, By Key Countries/Region, 2024
  • 4.2. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
  • 4.3. Overview: Regulatory & Reimbursement Scenario
  • 4.4. New Product Launches, By Key Players

5. Global Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Inflation Devices
    • 5.1.2. Guiding Devices
    • 5.1.3. Endoscopic Devices
    • 5.1.4. Laparoscopic Devices
    • 5.1.5. Robotic Assistive Surgery Devices
    • 5.1.6. Navigation & Visualization Systems
    • 5.1.7. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Cardiology
    • 5.2.2. Gastrointestinal
    • 5.2.3. Orthopedic
    • 5.2.4. Gynecological
    • 5.2.5. Neurology
    • 5.2.6. Dental
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Inflation Devices
    • 6.1.2. Guiding Devices
    • 6.1.3. Endoscopic Devices
    • 6.1.4. Laparoscopic Devices
    • 6.1.5. Robotic Assistive Surgery Devices
    • 6.1.6. Navigation & Visualization Systems
    • 6.1.7. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cardiology
    • 6.2.2. Gastrointestinal
    • 6.2.3. Orthopedic
    • 6.2.4. Gynecological
    • 6.2.5. Neurology
    • 6.2.6. Dental
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Inflation Devices
    • 7.1.2. Guiding Devices
    • 7.1.3. Endoscopic Devices
    • 7.1.4. Laparoscopic Devices
    • 7.1.5. Robotic Assistive Surgery Devices
    • 7.1.6. Navigation & Visualization Systems
    • 7.1.7. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cardiology
    • 7.2.2. Gastrointestinal
    • 7.2.3. Orthopedic
    • 7.2.4. Gynecological
    • 7.2.5. Neurology
    • 7.2.6. Dental
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia pacific Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Inflation Devices
    • 8.1.2. Guiding Devices
    • 8.1.3. Endoscopic Devices
    • 8.1.4. Laparoscopic Devices
    • 8.1.5. Robotic Assistive Surgery Devices
    • 8.1.6. Navigation & Visualization Systems
    • 8.1.7. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cardiology
    • 8.2.2. Gastrointestinal
    • 8.2.3. Orthopedic
    • 8.2.4. Gynecological
    • 8.2.5. Neurology
    • 8.2.6. Dental
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Inflation Devices
    • 9.1.2. Guiding Devices
    • 9.1.3. Endoscopic Devices
    • 9.1.4. Laparoscopic Devices
    • 9.1.5. Robotic Assistive Surgery Devices
    • 9.1.6. Navigation & Visualization Systems
    • 9.1.7. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cardiology
    • 9.2.2. Gastrointestinal
    • 9.2.3. Orthopedic
    • 9.2.4. Gynecological
    • 9.2.5. Neurology
    • 9.2.6. Dental
    • 9.2.7. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Minimally Invasive Surgery Devices Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Inflation Devices
    • 10.1.2. Guiding Devices
    • 10.1.3. Endoscopic Devices
    • 10.1.4. Laparoscopic Devices
    • 10.1.5. Robotic Assistive Surgery Devices
    • 10.1.6. Navigation & Visualization Systems
    • 10.1.7. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Cardiology
    • 10.2.2. Gastrointestinal
    • 10.2.3. Orthopedic
    • 10.2.4. Gynecological
    • 10.2.5. Neurology
    • 10.2.6. Dental
    • 10.2.7. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Johnson & Johnson Services, Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Koninklijke Philips N.V.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Boston Scientific Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Olympus Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Stryker
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. B. Braun SE
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Steris
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Intuitive Surgical
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2: Global Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 3: Global Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 4: Global Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 5: North America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 6: North America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 7: North America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 8: North America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country, 2019-2032
  • Table 9: Europe Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 10: Europe Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 11: Europe Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 12: Europe Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 13: Asia Pacific Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 14: Asia Pacific Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 15: Asia Pacific Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 16: Asia Pacific Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 17: Latin America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 18: Latin America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 19: Latin America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 20: Latin America Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 21: Middle East & Africa Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 22: Middle East & Africa Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 23: Middle East & Africa Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by End-user 2019-2032
  • Table 24: Middle East & Africa Minimally Invasive Surgery Devices Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Minimally Invasive Surgery Devices Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024 & 2032
  • Figure 4: Global Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024 & 2032
  • Figure 5: Global Minimally Invasive Surgery Devices Market Value (USD billion), by Region, 2024 & 2032
  • Figure 6: North America Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 7: North America Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 8: North America Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 9: North America Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 10: North America Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 11: North America Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 12: North America Minimally Invasive Surgery Devices Market Value (USD billion), By Country, 2024 & 2032
  • Figure 13: North America Minimally Invasive Surgery Devices Market Value Share (%), By Country, 2024
  • Figure 14: Europe Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 15: Europe Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 16: Europe Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 17: Europe Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 18: Europe Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 19: Europe Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 20: Europe Minimally Invasive Surgery Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 21: Europe Minimally Invasive Surgery Devices Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 22: Asia Pacific Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 23: Asia Pacific Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 24: Asia Pacific Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 25: Asia Pacific Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 27: Asia Pacific Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific Minimally Invasive Surgery Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Minimally Invasive Surgery Devices Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 31: Latin America Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 32: Latin America Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 33: Latin America Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 35: Latin America Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America Minimally Invasive Surgery Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 37: Latin America Minimally Invasive Surgery Devices Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Minimally Invasive Surgery Devices Market Value (USD billion), by Type, 2024 & 2032
  • Figure 39: Middle East & Africa Minimally Invasive Surgery Devices Market Value Share (%), by Type, 2024
  • Figure 40: Middle East & Africa Minimally Invasive Surgery Devices Market Value (USD billion), by Application, 2024 & 2032
  • Figure 41: Middle East & Africa Minimally Invasive Surgery Devices Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Minimally Invasive Surgery Devices Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 43: Middle East & Africa Minimally Invasive Surgery Devices Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa Minimally Invasive Surgery Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 45: Middle East & Africa Minimally Invasive Surgery Devices Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Minimally Invasive Surgery Devices Market Share (%), By Company, 2024